2008
DOI: 10.1002/mds.21930
|View full text |Cite
|
Sign up to set email alerts
|

Therapy‐refractory tourette syndrome: Beneficial outcome with globus pallidus internus deep brain stimulation

Abstract: We report on a female patient with Tourette syndrome and a 12-month follow-up after chronic deep brain stimulation in the globus pallidus internus which resulted in excellent remission of motor and vocal tics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
62
1
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 104 publications
(64 citation statements)
references
References 15 publications
0
62
1
1
Order By: Relevance
“…A case report detailing the 47% reduction in YGTSS associated with stimulation at the GPi for TS was published in 2005. 55 Multiple case reports 50,56,59,79,258 and small case series 49,185 followed, with the largest series reporting a mean decrease in YGTSS of 50%. 39 The only Class III evidence supporting use of GPi in TS comes from 2 single-subject, blinded cross-over trials comparing stimulation at the CM-PF to that of the GPi in patients implanted at both sites.…”
Section: Globus Pallidusmentioning
confidence: 99%
“…A case report detailing the 47% reduction in YGTSS associated with stimulation at the GPi for TS was published in 2005. 55 Multiple case reports 50,56,59,79,258 and small case series 49,185 followed, with the largest series reporting a mean decrease in YGTSS of 50%. 39 The only Class III evidence supporting use of GPi in TS comes from 2 single-subject, blinded cross-over trials comparing stimulation at the CM-PF to that of the GPi in patients implanted at both sites.…”
Section: Globus Pallidusmentioning
confidence: 99%
“…Typically, the therapy is used for conditions, such as Parkinson's disease and dystonia (Krauss et al, 1999;Starr et al, 2004;Rodriguez-Oroz et al, 2005;Bronstein et al, 2011), yet recently it has also been tried experimentally for treating BG-mediated hyperkinetic motor disorders, such as motor tics and Tourette syndrome (TS) (Vandewalle et al, 1999;van der Linden et al, 2002;Houeto et al, 2005;Shahed et al, 2007;Dehning et al, 2008;Dueck et al, 2009;MartinezTorres et al, 2009;Welter et al, 2010;Azoulay-Zyss et al, 2011;Martinez-Fernandez et al, 2011;Piedimonte et al, 2012). The emerging clinical data with respect to HF-DBS for TS is also supported by positive responses to stimulation in animal models of tourettism McCairn et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Multiple targets have been successful on a case-by-case basis, with the largest number of patients treated with bilateral implantation in the centromedian-parafascicular complex and ventralis oralis of the thalamus. 21 Other DBS targets, including the internal segment of the globus pallidus, 5,6,16 anterior limb of the internal capsule, 7,14 and nucleus accumbens, 14,17 have demonstrated a successful reduction in tic severity and comorbid obsessive-compulsive symptoms, a common clinical finding in patients with TS. 15 A reported case of TS with severe comorbid OCD and self-mutilation responded dramatically to DBS in the nucleus accumbens.…”
mentioning
confidence: 99%